![]() |
市場調查報告書
商品編碼
1559470
核磁共振 (NMR) 波譜儀 - 市場回顧、競爭格局、市場預測 (2030)Nuclear Magnetic Resonance (NMR) Spectrometer - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
估計2024年至2030年預測期內,全球核磁共振 (NMR) 波譜儀市場規模將以 5.21%的年複合成長率成長。由於更高的磁場強度和低溫冷卻探針等進步,提高了詳細分子研究的靈敏度和分辨率,預計市場將會成長。自動化高通量系統提高了資料收集效率並滿足快速分析的需求。在製藥和生物技術領域,核磁共振波譜儀透過提供精確的結構解析、化合物篩選、代謝物分析等,在藥物發現和開發中發揮非常重要的作用。生物製劑的重要性日益增加,凸顯了對核磁共振等先進技術的需求。此外,代謝組學和代謝分析在個人化醫療和生物標記發現中的越來越多的使用進一步推動了2024-2030年預測期內的市場成長。
核磁共振 (NMR) 波譜儀市場動態
在藥物發現和開發中,核磁共振波譜對於確定新化合物的結構和篩選潛在候選藥物的大型庫非常重要。它透過提供詳細的分子成分資訊來檢測雜質並確保批次一致性,在品質控制和保證中發揮關鍵作用。此外,監管合規性進一步推動了對 NMR 的需求,因為它提供了藥物審批所需的全面分子資料。核磁共振技術的進步,包括提高靈敏度和解析度、自動化和高通量系統,日益增加其對製藥應用的吸引力。
此外,生物製劑和複雜分子的增加也增加了對 NMR 等先進分析技術的需求。協作研究和外包趨勢促進市場成長,製藥公司依賴專門的NMR 設施來滿足其分析需求。總體而言,藥品複雜性的增加、對詳細分子分析的需求以及嚴格的監管要求是推動核磁共振波譜儀市場擴張的主要因素。
推動核磁共振 (NMR) 波譜儀市場擴張的另一個因素是臨床試驗活動的增加。例如,2024年5月,Arvinas, Inc. 和Pfizer Inc. 宣布了評估 vepdegestrant 的1b 期聯合隊列的最新臨床資料,一種研究性口服蛋白水解靶向嵌合體 (PROTAC (R) ) 雌激素受體 (ER) 降解劑,與 palbociclib (IBRANCE (R) ) 聯合使用。
因此,製藥公司依靠 NMR 在這些階段進行精確的結構闡明、化合物篩選和代謝物分析。隨著越來越多的藥物進行臨床試驗,對核磁共振波譜儀支持潛在候選藥物的表徵和驗證的需求將會增加。核磁共振波譜儀需求的預期激增預計將推動2024-2030年預測期內核磁共振波譜儀市場的整體成長。
然而,缺乏訓練有素的人員來有效操作核磁共振設備以及核磁共振的高成本可能會限制整體市場的成長。
核磁共振 (NMR) 波譜儀市場區隔分析
在整個核磁共振 (NMR) 波譜儀市場的產品類型部分,儀器類別預計將在2023年佔據最大佔有率。儀器核磁共振的巨大市場佔有率是由其眾多優勢推動的。儀器式核磁共振波譜儀具有無數的優點,使其成為各領域不可或缺的分析技術。首先,它允許無損分析,保留樣品的完整性以供後續實驗和進一步分析。 NMR 產生詳細的結構訊息,揭示溶液中分子的化學成分、組織和空間排列。
此外,濃度和化學計量的精確測定有利於定量分析。其多功能性擴展到多種樣品類型,包括有機小分子、蛋白質、核酸、聚合物和複雜混合物,並允許分析各種狀態的樣品,包括溶液、固體和氣體。此外,核磁共振波譜透過弛豫測量和擴散核磁共振等技術,可以深入了解分子動力學,包括結構變化、運動和相互作用。現代儀器具有靈敏度和選擇性,可以檢測低濃度的化合物,並為分子內的不同核提供不同的訊號。
本報告研究和分析了全球核磁共振 (NMR) 波譜儀市場,提供了每個地區的市場規模和預測、過去三年的產品/技術發展以及每個細分市場的業績和前景等訊息。
Nuclear Magnetic Resonance (NMR) Spectroscopy Market By Product Type (Instruments, Accessories), By Type (Low-Field NMR Spectroscopy, High-Field NMR Spectroscopy), End-User (Academic, Pharmaceutical & Biotech Companies, Agriculture & Food, And Others) And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to demand for drug discovery and drug administration in pharmaceutical companies among others
The Nuclear Magnetic Resonance (NMR) Spectroscopy market is estimated to grow at a CAGR of 5.21% during the forecast period from 2024 to 2030. The NMR Spectroscopy market is set for growth due to advancements like higher magnetic field strengths and cryogenically cooled probes, which improve sensitivity and resolution for detailed molecular studies. Automated, high-throughput systems enhance data collection efficiency, meeting the need for rapid analysis. In the pharmaceutical and biotechnology sectors, NMR spectroscopy plays a pivotal role in drug discovery and development by providing precise structural elucidation, compound screening, and metabolite analysis. The increasing importance of biologics highlights the need for sophisticated techniques like NMR. Additionally, expanding applications in metabolomics and personalized medicine for metabolite profiling and biomarker discovery further drives the market growth during the forecast period of 2024 to 2030.
Nuclear Magnetic Resonance (NMR) Spectroscopy Market Dynamics:
In drug discovery and development, NMR spectroscopy is essential for determining the structure of new compounds and screening large libraries of potential drug candidates. It plays a critical role in quality control and assurance by providing detailed molecular composition information to detect impurities and ensure batch consistency. Additionally, regulatory compliance further drives the demand for NMR as it provides comprehensive molecular data required for drug approval. Advancements in NMR technology, such as improved sensitivity and resolution, along with automation and high-throughput systems, make it increasingly attractive for pharmaceutical applications.
Additionally, the rise of biologics and complex molecules also boosts the need for advanced analytical techniques like NMR. Collaborative research and outsourcing trends contribute to market growth, the pharmaceutical companies rely on specialized NMR facilities for their analytical needs. Overall, the increasing complexity of drugs, the need for detailed molecular analysis, and stringent regulatory requirements are key drivers for the expanding NMR spectroscopy market.
Another factor driving the expansion of the Nuclear Magnetic Resonance (NMR) Spectroscopy market is the increase in clinical trial activity. For example, in May 2024,
Arvinas, Inc. and Pfizer Inc. announced updated clinical data from a Phase 1b combination cohort that evaluated vepdegestrant, an investigational oral PROteolysis TArgeting Chimera (PROTAC(R)) estrogen receptor (ER) degrader, in combination with palbociclib (IBRANCE(R)).
Thus, pharmaceutical companies rely on NMR for accurate structural elucidation, compound screening, and metabolite analysis during these phases. As more drugs undergo clinical trials, the demand for NMR spectroscopy increases to support the characterization and validation of potential drug candidates. The expected surge in demand for NMR Spectroscopy is projected to fuel the growth of the overall NMR Spectroscopy market throughout the forecast period from 2024 to 2030.
However, the lack of well-trained individuals who can effectively operate NMR devices, and the high cost of NMR may restrict the growth of the overall Nuclear Magnetic Resonance (NMR) Spectroscopy market.
Nuclear Magnetic Resonance (NMR) Spectroscopy Market Segment Analysis:
Nuclear Magnetic Resonance (NMR) Spectroscopy Market by Product Type (Instruments, Accessories), Type (Low-Field NMR Spectroscopy, High-Field NMR Spectroscopy), End-User (Academic, Pharmaceutical & Biotech Companies, Agriculture & Food, and others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the overall Nuclear Magnetic Resonance (NMR) Spectroscopy market, the Instrument category is expected to hold the largest share in the year 2023. The large market share of Instrument NMR is driven by its numerous advantages, Instrumental NMR spectroscopy offers a myriad of advantages that make it an indispensable analytical technique across various fields. Firstly, it provides non-destructive analysis, preserving the integrity of samples for subsequent experiments or further analysis. NMR yields detailed structural information that clarifies the chemical composition, configurations, and spatial arrangements of molecules in solution.
Moreover, it facilitates quantitative analysis by determining concentrations and stoichiometry accurately. Its versatility extends to a wide range of sample types, including small organic molecules, proteins, nucleic acids, polymers, and complex mixtures, and it can analyze samples in different states such as solutions, solids, and gases. Additionally, NMR spectroscopy provides insights into molecular dynamics, including conformational changes, motions, and interactions, through techniques like relaxation measurements and diffusion NMR. Modern instruments offer high sensitivity and selectivity, enabling the detection of low-concentration compounds and providing distinct signals for different nuclei within a molecule.
Furthermore, NMR spectroscopy can be adapted for imaging applications such as Magnetic Resonance Imaging (MRI), allowing non-invasive visualization of internal structures in biological systems with excellent spatial resolution. These collective advantages underscore the pivotal role of NMR spectroscopy in scientific research, and clinical applications.
As the demand for this segment grows, various novel products are launched by various players operating in the market across the world. For example, in April 2023, Nanalysis Scientific Corp announced that QUAD Systems debuted the new 400MHz High Field NMR system in collaboration with Nanalysis at the Experimental Nuclear Magnetic Resonance Conference (ENC 2023) in Pacific Grove, California.
Therefore, owing to the aforementioned advantages of the NMR devices, the market is expected to grow thereby propelling the overall market growth for Nuclear Magnetic Resonance (NMR) Spectroscopy during the forecast period from 2024 to 2030.
North America Is Expected To Dominate The Overall Nuclear Magnetic Resonance (NMR) Spectroscopy Market:
Among all the regions, North America is expected to hold the largest share of the global Nuclear Magnetic Resonance (NMR) Spectroscopy market in 2023. The NMR Spectroscopy market in North America is expected to grow significantly due to several factors. Advancements in technology, such as higher field strength magnets and enhanced software capabilities, are making NMR instruments more efficient and user-friendly. Further, strong research and development infrastructure, and strategic collaborations among the key players in the region is also driving the market growth. The region's focus on personalized medicine and biopharmaceuticals fuels demand, while its healthcare market increasingly utilizes NMR spectroscopy in clinical research and diagnostics. These combined factors are boosting the NMR spectroscopy market in North America.
Also, the region boasts a robust research and development infrastructure across academia and industry. Major pharmaceutical, biotechnology, and chemical companies, alongside leading academic institutions, heavily invest in NMR spectroscopy for crucial research in drug discovery, structural biology, and materials science.
Additionally, North America's healthcare market, characterized by significant investments in research, diagnostics, and therapeutics, increasingly utilizes NMR spectroscopy in clinical research, biomarker discovery, and diagnostic imaging, further contributing to market growth. Compliance with regulatory standards drives adoption for quality control, validation, and compliance testing, further boosting market growth.
Furthermore, recent strategic initiatives and various product launches of NMR Spectroscopy are also aiding in driving the market growth of NMR Spectroscopy in the region. For example, in April 2023, Bruker launched the Ascend Evo 400, a new standard 400 MHz NMR magnet with a liquid helium hold time of one year to reduce the cost of ownership and enhance operational convenience.
Therefore, the interplay of all the aforementioned factors, among others is expected to boost the growth of the Nuclear Magnetic Resonance (NMR) Spectroscopy market in the North America region during the forecast period from 2024 to 2030.
Nuclear Magnetic Resonance (NMR) Spectroscopy Market Key Players:
Some of the key market players operating in the Nuclear Magnetic Resonance (NMR) Spectroscopy market include Bruker, Oxford Instruments, JEOL Ltd., magritek, Thermo Fisher Scientific Inc., Anasazi Instruments, Inc., Nanalysis, Shimadzu Corporation, Quantum Design Inc., Horiba, Oxford Instruments, Spinlock, QUAD Systems, BLUEFORS, BUCHI, and others.
Recent Developmental Activities In The Nuclear Magnetic Resonance (NMR) Spectroscopy Market:
Key Takeaways From The Nuclear Magnetic Resonance (NMR) Spectroscopy Market Report Study:
Target Audience Who Can Be Benefited From This Nuclear Magnetic Resonance (NMR) Spectroscopy Market Report Study:
Frequently Asked Questions For The Nuclear Magnetic Resonance (NMR) Spectroscopy Market:
Nuclear Magnetic Resonance (NMR) spectroscopy is a powerful analytical technique used to determine the structure, dynamics, reaction state, and chemical environment of molecules. It exploits the magnetic properties of certain atomic nuclei.
The Nuclear Magnetic Resonance (NMR) Spectroscopy market is estimated to grow at a CAGR of 5.21% during the forecast period from 2024 to 2030.
The NMR Spectroscopy market is set for growth due to advancements like higher magnetic field strengths and cryogenically cooled probes, which improve sensitivity and resolution for detailed molecular studies. Automated, high-throughput systems enhance data collection efficiency, meeting the need for rapid analysis. In the pharmaceutical and biotechnology sectors, NMR spectroscopy plays a pivotal role in drug discovery and development by providing precise structural elucidation, compound screening, and metabolite analysis. The increasing importance of biologics highlights the need for sophisticated techniques like NMR. Additionally, expanding applications in metabolomics and personalized medicine for metabolite profiling and biomarker discovery further drives the market growth during the forecast period of 2024 to 2030.
Some of the key market players operating in the Nuclear Magnetic Resonance (NMR) Spectroscopy market include Bruker, Oxford Instruments, JEOL Ltd., Magritek, Thermo Fisher Scientific Inc., Anasazi Instruments, Inc., Nanalysis, Shimadzu Corporation, Quantum Design Inc., Horiba, Oxford Instruments, Spinlock, QUAD Systems, BLUEFORS, BUCHI, and others.
Among all the regions, North America is expected to hold the largest share of the global Nuclear Magnetic Resonance (NMR) Spectroscopy market in 2023. The NMR Spectroscopy market in North America is expected to grow significantly due to several factors. Advancements in technology, such as higher field strength magnets and enhanced software capabilities, are making NMR instruments more efficient and user-friendly. Further, strong research and development infrastructure, and strategic collaborations among the key players in the region is also driving the market growth. The region's focus on personalized medicine and biopharmaceuticals fuels demand, while its healthcare market increasingly utilizes NMR spectroscopy in clinical research and diagnostics. These combined factors are boosting the NMR spectroscopy market in North America.